Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 95

1.

Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway.

Zheng A, Song X, Zhang L, Zhao L, Mao X, Wei M, Jin F.

J Exp Clin Cancer Res. 2019 Jul 12;38(1):305. doi: 10.1186/s13046-019-1315-8.

2.

Identification of potential key genes and pathways predicting pathogenesis and prognosis for triple-negative breast cancer.

Lv X, He M, Zhao Y, Zhang L, Zhu W, Jiang L, Yan Y, Fan Y, Zhao H, Zhou S, Ma H, Sun Y, Li X, Xu H, Wei M.

Cancer Cell Int. 2019 Jun 28;19:172. doi: 10.1186/s12935-019-0884-0. eCollection 2019.

3.

TROAP Promotes Breast Cancer Proliferation and Metastasis.

Li K, Zhang R, Wei M, Zhao L, Wang Y, Feng X, Yang Y, Yang S, Zhang L.

Biomed Res Int. 2019 May 6;2019:6140951. doi: 10.1155/2019/6140951. eCollection 2019.

4.

Inhibition of SMYD2 Sensitized Cisplatin to Resistant Cells in NSCLC Through Activating p53 Pathway.

Shang L, Wei M.

Front Oncol. 2019 Apr 26;9:306. doi: 10.3389/fonc.2019.00306. eCollection 2019.

5.

Clinical implications of a novel prognostic factor AIFM3 in breast cancer patients.

Zheng A, Zhang L, Song X, Wang Y, Wei M, Jin F.

BMC Cancer. 2019 May 14;19(1):451. doi: 10.1186/s12885-019-5659-4.

6.

The Analysis of Key Factors Related to ADCs Structural Design.

Tang H, Liu Y, Yu Z, Sun M, Lin L, Liu W, Han Q, Wei M, Jin Y.

Front Pharmacol. 2019 Apr 24;10:373. doi: 10.3389/fphar.2019.00373. eCollection 2019. Review.

7.

A mutual activation loop between the Ca2+-activated chloride channel TMEM16A and EGFR/STAT3 signaling promotes breast cancer tumorigenesis.

Wang H, Yao F, Luo S, Ma K, Liu M, Bai L, Chen S, Song C, Wang T, Du Q, Wu H, Wei M, Fang Y, Xiao Q.

Cancer Lett. 2019 Jul 28;455:48-59. doi: 10.1016/j.canlet.2019.04.027. Epub 2019 Apr 28.

PMID:
31042586
8.

Skp2 inhibitor SKPin C1 decreased viability and proliferation of multiple myeloma cells and induced apoptosis.

Yang Y, Yan W, Liu Z, Wei M.

Braz J Med Biol Res. 2019;52(5):e8412. doi: 10.1590/1414-431X20198412. Epub 2019 Apr 25.

9.

Differential Expression of mRNAs in the Brain Tissues of Patients with Alzheimer's Disease Based on GEO Expression Profile and Its Clinical Significance.

Ma G, Liu M, Du K, Zhong X, Gong S, Jiao L, Wei M.

Biomed Res Int. 2019 Feb 26;2019:8179145. doi: 10.1155/2019/8179145. eCollection 2019.

10.

The long non-coding RNA LINC00460 predicts the prognosis and promotes the proliferation and migration of cells in bladder urothelial carcinoma.

Wen L, Zhang X, Bian J, Han L, Huang H, He M, Wei M, Wang P.

Oncol Lett. 2019 Apr;17(4):3874-3880. doi: 10.3892/ol.2019.10023. Epub 2019 Feb 7.

11.

Histone H3 trimethylation at lysine 36 guides m6A RNA modification co-transcriptionally.

Huang H, Weng H, Zhou K, Wu T, Zhao BS, Sun M, Chen Z, Deng X, Xiao G, Auer F, Klemm L, Wu H, Zuo Z, Qin X, Dong Y, Zhou Y, Qin H, Tao S, Du J, Liu J, Lu Z, Yin H, Mesquita A, Yuan CL, Hu YC, Sun W, Su R, Dong L, Shen C, Li C, Qing Y, Jiang X, Wu X, Sun M, Guan JL, Qu L, Wei M, Müschen M, Huang G, He C, Yang J, Chen J.

Nature. 2019 Mar;567(7748):414-419. doi: 10.1038/s41586-019-1016-7. Epub 2019 Mar 13.

PMID:
30867593
12.

Combining Red Blood Cell Distribution Width (RDW-CV) and CEA Predict Poor Prognosis for Survival Outcomes in Colorectal Cancer.

Li Y, Xing C, Wei M, Wu H, Hu X, Li S, Sun G, Zhang G, Wu B, Zhang F, Li Z.

J Cancer. 2019 Jan 29;10(5):1162-1170. doi: 10.7150/jca.29018. eCollection 2019.

13.

Cetuximab-modified silica nanoparticle loaded with ICG for tumor-targeted combinational therapy of breast cancer.

Zhang X, Li Y, Wei M, Liu C, Yang J.

Drug Deliv. 2019 Dec;26(1):129-136. doi: 10.1080/10717544.2018.1564403.

14.

Identification of a novel glycolysis-related gene signature that can predict the survival of patients with lung adenocarcinoma.

Liu C, Li Y, Wei M, Zhao L, Yu Y, Li G.

Cell Cycle. 2019 Mar;18(5):568-579. doi: 10.1080/15384101.2019.1578146. Epub 2019 Feb 17.

PMID:
30727821
15.
16.

Moesin is an independent prognostic marker for ER-positive breast cancer.

Yu L, Zhao L, Wu H, Zhao H, Yu Z, He M, Jin F, Wei M.

Oncol Lett. 2019 Feb;17(2):1921-1933. doi: 10.3892/ol.2018.9799. Epub 2018 Dec 6.

17.

Polymorphisms in DNA repair pathway genes and ABCG2 gene in advanced colorectal cancer: correlation with tumor characteristics and clinical outcome in oxaliplatin-based chemotherapy.

Hu X, Qin W, Li S, He M, Wang Y, Guan S, Zhao H, Yao W, Wei M, Liu M, Wu H.

Cancer Manag Res. 2018 Dec 27;11:285-297. doi: 10.2147/CMAR.S181922. eCollection 2019.

18.

MFG-E8 overexpression is associated with poor prognosis in breast cancer patients.

Yu L, Zhao L, Jia Z, Bi J, Wei Q, Song X, Jiang L, Lin S, Wei M.

Pathol Res Pract. 2019 Mar;215(3):490-498. doi: 10.1016/j.prp.2018.12.036. Epub 2018 Dec 31.

PMID:
30612778
19.

Prognostic relevance of miR-137 and its liver microenvironment regulatory target gene AFM in hepatocellular carcinoma.

Wei Q, Zhao L, Jiang L, Bi J, Yu Z, Zhao L, Song X, Sun M, Chen Y, Wei M.

J Cell Physiol. 2019 Jul;234(7):11888-11899. doi: 10.1002/jcp.27855. Epub 2018 Dec 6.

PMID:
30523640
20.

Hypoxia-inducible factor-2α directly promotes BCRP expression and mediates the resistance of ovarian cancer stem cells to adriamycin.

He M, Wu H, Jiang Q, Liu Y, Han L, Yan Y, Wei B, Liu F, Deng X, Chen H, Zhao L, Wang M, Wu X, Yao W, Zhao H, Chen J, Wei M.

Mol Oncol. 2019 Feb;13(2):403-421. doi: 10.1002/1878-0261.12419. Epub 2019 Jan 14.

Supplemental Content

Loading ...
Support Center